Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The Nurse Case Manager (RNCM) role sits at the intersection of patient advocacy, insurance policy, and product access, making this a critical role in supporting patients who have been prescribed a Revolution Medicines' therapy.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
AmeriPharma